Beijing Leadman Biochemistry Co., Ltd. (300289)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
5. 98
-0.09
-1.4827%
¥
4.09B Market Cap
- P/E Ratio
0.01% Div Yield
6.36M Volume
- Eps
¥ 6.07
Previous Close Want to track 300289 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300289 closed today lower at ¥5.98, a decrease of -1.4827% from yesterday's close, completing a monthly increase of 7.554% or ¥0.42. Over the past 12 months, 300289 stock lost -14.2037%.
300289 is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0023%, based on the last three reports.
Beijing Leadman Biochemistry Co., Ltd. has completed 1 stock splits, with the recent split occurring on Oct 27, 2015.
The company's stock is traded on one exchange.
300289 Chart
People also search for
Beijing Leadman Biochemistry Co., Ltd. (300289) FAQ
What is the stock price today?
The current price is ¥5.98.
On which exchange is it traded?
Beijing Leadman Biochemistry Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300289.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.01%.
What is its market cap?
As of today, the market cap is 4.09B.
Has Beijing Leadman Biochemistry Co., Ltd. ever had a stock split?
Beijing Leadman Biochemistry Co., Ltd. had 1 splits and the recent split was on Oct 27, 2015.
Beijing Leadman Biochemistry Co., Ltd. Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Ouyang Xu CEO | XSHE Exchange | CNE100001C22 ISIN |
| CN Country | 468 Employees | 17 May 2024 Last Dividend | 27 Oct 2015 Last Split | 16 Feb 2012 IPO Date |
Overview
Beijing Leadman Biochemistry Co., Ltd., established in 1997 and headquartered in Beijing, People's Republic of China, specializes in the research and development, manufacturing, and marketing of in vitro diagnostic reagents and instruments, along with biochemical raw materials. The company serves a wide range of industries including biotechnology, clinical diagnostics, drug development, and chemical production, highlighting its significance in contributing to medical advancements and healthcare services in China.
Products and Services
- Biochemical Raw Materials: This includes a variety of essential biochemicals such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain reagents, amino acids, and more. These materials find applications in biotechnology, clinical diagnosis, drug development, and chemical production.
- Diagnostic and Companion Reagents: The company provides a comprehensive array of biochemistry diagnostic and companion reagents covering areas such as liver function, lipid profiles, diabetes, pancreas function, tumor detection, coagulation, cardiac markers, electrolytes, renal function, thyroid and sex hormones, infectious diseases, and proteins.
- Medical Instruments:
- EnigmaML: An automated molecular test platform intended for clinical laboratories and point-of-care settings, including clinics and pharmacies, facilitating fast and accurate testing.
- DiaSys InnovaStar: An automatic compact POCT (Point of Care Testing) analyzer that provides laboratory-quality results for on-the-spot diagnostics.
- DiaSys Respons: A bench-top analyzer designed for random-access testing, offering flexibility and convenience for small to medium-sized lab environments.
- CI1000: An automatic chemiluminescence immunoassay analyzer geared towards high-throughput and accurate diagnostic testing.
- IDS-isys: An instrument enhancing performance and productivity in clinical diagnostics with its advanced features and high efficiency.
Contact Information
Address: No.5 Xinghai Road, Beijing, China, 100176
Phone: 86 10 6785 5500
Website: https://www.leadmanbio.com
